Brian Leedman’s BlinkLab to join ASX: AI-driven smartphone app screens for autism, ADHD
BlinkLab is a world-first, AI-driven digital healthcare venture, that uses a smartphone and facial recognition to detect autism and ADHD. It’s listing on the ASX next Thursday (April 4) under the code BB1. BlinkLab’s development is being led by chair Brian Leedman - a founder of ResApp Health - the cough analysis app sold to Pfizer two years ago in a $179 million deal.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
TIL | Ann: TIL to delist | 12/04/18 | 0 | 1.0K | |||
|
|||||||
TIL | Ann: TIL Notification of allotment of securities | 11/04/18 | 0 | 890 | |||
|
|||||||
TIL | Ann: Trilogy International Limited ("TIL") - Delisting | 09/04/18 | 0 | 830 | |||
|
|||||||
TIL | Ann: Trilogy International Ltd (TIL) - Suspension of Securities | 06/04/18 | 0 | 682 | |||
|
|||||||
TIL | Ann: Scheme of Arrangement – Timetable | 05/04/18 | 0 | 730 | |||
|
|||||||
TIL | Ann: SPH Notice | 11:11 | 0 | 778 | |||
|
|||||||
TIL | Ann: Scheme of Arrangement – Final High Court Orders | 09:43 | 0 | 782 | |||
|
|||||||
TIL | Ann: SPH Notice - Credit Suisse Holdings (Australia) Limited | 28/03/18 | 0 | 735 | |||
|
See All Discussions